A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines



Status:Completed
Conditions:Migraine Headaches
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - 65
Updated:4/21/2016
Start Date:May 2013
End Date:May 2014

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

This study will evaluate the effectiveness and benefit of treatment with onabotulinumtoxinA
in Chronic Migraine patients who have received a minimum of 7 treatment cycles.


Inclusion Criteria:

- 15 or more headache days over a 30 day period

- A minimum of 7 treatment cycles with onabotulinumtoxinA

Exclusion Criteria:

- Any treatment cycle dose of onabotulinumtoxinA greater than 200 units
We found this trial at
1
site
Clinical Trial Facility in Encinitas California
Encinitas, California 92024
?
mi
from
Encinitas, CA
Click here to add this to my saved trials